Introduction

The term "mediastinitis" describes an infection or inflammation of the mediastinum, the centre chamber of the thoracic cavity. This chamber contains important anatomical features such as the heart, trachea, esophagus, and major blood veins. Due to its proximity to these crucial anatomical features, mediastinitis poses a significant risk of morbidity and mortality, making it a life-threatening illness. Immediate and aggressive therapy coupled with intensive care is frequently required to avoid serious problems arising from this illness.¹

An uncommon but extremely severe type of Mediastinitis is called Fibrosing Mediastinitis and is caused by an overabundance of fibrous tissue forming in the mediastinum, compressing and obstructing mediastinal structures. Effective care for this fibrosis depends on early detection and knowledge of its aetiology and risk factors, as it can seriously affect the function of vital organs and arteries.

This article will examine several risk factors and etiological factors linked to Fibrosing Mediastinitis. The purpose of this article is to clarify the complicated mechanisms behind this disorder and identify areas that require further investigation and clinical attention. This will be done by looking at viral and non-infectious causes, as well as demographic and medical risk factors.

Aetiology and risk factors

The rare disease known as Fibrosing Mediastinitis (FM) is characterised by dense, invasive, fibrotic infiltration of the hilar regions (the space between the upper and lower lobes of each lung) and/or the mediastinum (the middle portion of the chest, located between the lungs). This infiltration narrows or obstructs important chest structures, such as the oesophagus, the superior vena cava, the pulmonary veins, the pulmonary arteries, and the pulmonary veins.²
A variety of illnesses, including iatrogenic, traumatic, and viral ones, can compromise the integrity of the mediastinal structures and result in mediastinitis. Furthermore, a weakened immune system can also make a human body more prone to be diagnosed with Fibrosing Mediastinitis.³

Although many factors have to be considered to determine the cause of Fibrosing Mediastinitis, it's crucial to know that tracheal or esophageal rupture—which can happen after an endoscopic operation, as in the case of Boerhaave syndrome, or foreign body aspiration—is a common cause of mediastinitis. In rare cases, pancreatitis, the spread of lung infection, and direct trauma are other causes of mediastinitis. Research on the precise aetiology of fibrosing mediastinitis is currently lacking. Despite being idiopathic, there has been conjecture that it is linked to both infectious and noninfectious causes. Histoplasmosis and tuberculosis are two possible pathogenic causes that have been commonly associated in the literature with an immune-mediated hypersensitivity reaction. Riedel thyroiditis, retroperitoneal fibrosis, and sarcoidosis are among the non-infectious reasons that are frequently mentioned.

Reverting to histoplasmosis, the most prevalent endemic parasitic fungus in the US, Histoplasma Capsulatum, is the cause of histoplasmosis. It lives in soil and grows in wide geographic areas of endemicity, mostly along the Mississippi and Ohio River valleys, when certain requirements related to temperature, humidity, nitrogen content, and acidity are met. On rare occasions, it also spreads illness to South and Central America. While histoplasmosis is less common in these areas, histoplasma species are also present throughout Europe, Asia, Africa, and Australia. In addition, it grows in soil that has been enhanced by the droppings of birds and is present in bat guano; guano-contaminated chicken houses, tunnels, and underpasses under bridges are well-known sources of H. Capsulatum infections.²

Diagnosis

Granulomatous and Nongranulomatous are the two main subtypes of FM. The main causes of the granulomatous form of FM are tuberculosis and histoplasmosis, whereas non-granulomatous FM is an idiopathic response to radiation, medications (such as methysergide), and autoimmune disorders. It is often linked to other fibrosing disorders such as ocular pseudo-tumours, primary sclerosing cholangitis, and retroperitoneal fibrosis. Patients should have an immediate primary assessment of their respiration, circulation, and airway if they have any suspicions of Mediastinitis. If needed, resuscitation techniques ought to come before laboratory and imaging tests. The next step to examine for a diagnosis is to obtain crucial imaging once the patient has stabilised. If there are indications of pneumomediastinum or mediastinal enlargement, a chest radiograph may be useful; however, it frequently fails to accurately depict the extent of the disease process.²

Most patients arrive with symptoms such as increasing dyspnoea, facial puffiness, conjunctival suffusion, headache, giddiness, etc. that are caused by compression of the mediastinal broncho vascular systems. Widening of the mediastinum and swollen lymph nodes in the subcarinal, hilar (unilateral or bilateral), and paratracheal regions are examples of non-specific features that may be seen on a chest radiograph. These characteristics can occasionally result in trachea and bronchial constriction.⁴
In conclusion, when a young child arrives with symptoms of broncho vascular compression, such as progressive dyspnoea, chest pain, facial puffiness, conjunctival suffusion, headache, and giddiness, FM should be taken into consideration in the differential diagnosis.⁵

To put this into perspective, the following case study shows the difficulty in diagnosing FM. A 38-year-old woman had her first bout of histoplasmosis and then developed fibrosing mediastinitis. She had a history of recurrent bronchitis as a teenager, and she started exhibiting signs of pneumonia that weren't alleviated by traditional treatments. Her right lung infiltrates were accompanied by mediastinal lymphadenopathy. She was treated with oral itraconazole following the confirmation of her histoplasmosis through transbronchial biopsy. She first had worsening dyspnoea with exertion three years after starting itraconazole medication. Echocardiography revealed significant tricuspid regurgitation and new-onset pulmonary hypertension. A cross-sectional image of the chest showed calcified, enlarged lymph nodes; thickened pericardium and pleura; and noticeable fibrosis in the hilar region. The diagnosis of Fibrosing Mediastinitis was validated by thorascopic and mediastinoscopic biopsies.⁶ This case study is evidence that FM can be commonly misdiagnosed and that a thorough investigation into the symptoms shown, as well as the choice of tests is crucial to properly diagnose FM.

Summary

A rare but dangerous disorder known as Fibrosing Mediastinitis is characterised by the development of fibrous tissue in the mediastinum, which compresses important thoracic structures. Histoplasmosis is the main causative factor, especially in areas where it is endemic, however, tuberculosis, autoimmune diseases, and idiopathic factors can also cause FM. Although the clinical presentation can vary, compression of the blood vessels and airways can result in vascular and respiratory complaints.

Imaging methods like CT and MRI are crucial for the diagnosis since they show distinctive dense fibrotic tumours. The diagnosis is validated by histopathological investigation, which shows persistent inflammation and extensive collagen deposition. There are still few treatment options available, and they mostly focus on managing problems and relieving symptoms. Antifungal therapy may be helpful in cases associated with histoplasmosis; nevertheless, because the condition is progressing, the overall prognosis is uncertain.

For an early diagnosis and successful treatment of fibrosing mediastinitis, knowledge of the etiology and risk factors is essential. To investigate more potent therapy approaches and enhance patient outcomes, further research is required. Improved diagnostic methods and increased knowledge of this difficult condition will help healthcare professionals better manage it and ultimately lower the morbidity and death that come with it.